Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

China · Delayed Price · Currency is CNY

16.47

+0.08 (0.49%)

Sep 4, 2026, 3:04 PM CST

SHE:000766 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	1,077	1,170	1,323	1,473	1,471	1,515
Revenue Growth	-18.61%	-11.54%	-10.23%	0.18%	-2.95%	36.31%
Gross Profit	784.06	844.95	993.53	1,092	1,118	1,165
Operating Income	100.94	114.52	140.39	121.75	120.96	113.33
Net Income	24.59	34.29	56.44	43.93	30.15	35.27
Earnings Per Share	0.03	0.04	0.06	0.05	0.03	0.04
EPS Growth	-55.47%	-33.33%	20.00%	66.67%	-25.00%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	488.97	273.18	275.27	178.49	336.95	301.77
Total Debt	2,022	1,815	1,802	1,703	1,798	1,853
Net Cash (Debt)	-1,533	-1,542	-1,527	-1,524	-1,461	-1,551
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.79	-1.80	-1.62	-1.73	-1.45	-1.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	83.56	105.05	162.75	112.78	198.16	138.33
Capital Expenditures	-55.93	-64.07	-49.17	-26.67	-23.74	-25.48
Free Cash Flow	27.63	40.99	113.58	86.11	174.42	112.85
Free Cash Flow Growth	-82.62%	-63.91%	31.89%	-50.63%	54.56%	83.35%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	72.79%	72.22%	75.12%	74.13%	76.00%	76.89%
Operating Margin	9.37%	9.79%	10.62%	8.26%	8.22%	7.48%
Pretax Margin	2.78%	3.65%	5.07%	3.72%	3.41%	3.93%
Profit Margin	2.28%	2.93%	4.27%	2.98%	2.05%	2.33%
FCF Margin	2.56%	3.50%	8.59%	5.85%	11.86%	7.45%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	647.42	774.91	268.86	438.66	168.93	130.15
Forward PE	-	15.74	15.74	15.74	15.74	15.74
P/FCF Ratio	576.05	648.21	133.60	223.80	29.20	40.68
PS Ratio	14.78	22.71	11.47	13.08	3.46	3.03